FierceBiotech
Media & Internet · Missouri, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1001 NW Technology Dr, Lees Summit, Miss...Website
www.fiercebiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About FierceBiotech
Fierce Biotech is a leading source of news and reports focused on the biotechnology sector, covering topics such as clinical data, cell and gene therapy, and venture capital. The company provides insights into the latest developments in medtech, diagnostics, and biologics, catering to professionals in the life sciences industry. It also hosts events, webinars, and awards to recognize innovation and excellence in healthcare and science. Fierce Biotech aims to inform and connect stakeholders in the biotech community, including researchers, investors, and healthcare professionals.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is FierceBiotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when FierceBiotech launches new products
Congratulate Masked Content for being promoted to Masked Content at FierceBiotech
Earning: See what the market has to say on FierceBiotech recently announced quarterly report
Click to see if FierceBiotech had a recent Job posting/layoffs
FierceBiotech, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once FierceBiotech has new funding data
Check if FierceBiotech has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if FierceBiotech is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined FierceBiotech as Masked Content
Find more new buyers
Compare Similar Companies to FierceBiotech
Compare insights from companies similar to FierceBiotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
FierceBiotech
<$5M
1-10
Private
-
2008
N/A
Company Profile Activity
Activity Insights
FierceBiotech is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
FierceBiotech is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about FierceBiotech.
FierceBiotech Tech Stack
A closer look at the technologies used by FierceBiotech
FierceBiotech News & Media
Questex’s Fierce Biotech Announces 2026 Fierce Outsourcing Award Winners, Honoring Excellence Across the Drug Development Ecosystem
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Questex’s Fierce Biotech today announces the winners of the 2026 Fierce Outsourcing Awards, recognizing the companies and teams driving innovation, performance, and partnership across the outsourced drug development landscape.Sensei Biotherapeutics Merges with Faeth Therapeutics, Secures $200M Funding
Only a couple of months ago, Sensei Biotherapeutics was laying off staff and mulling winding down the company. But the biotech has found a new lease on life—and a new lead drug—via a merger with Faeth Therapeutics. Shareholders of privately owned Faeth will own 40.8% of the merged company, while Sensei's current shareholders will own 4.9%. The rest will be owned by investors that participated in a $200 million private placement.Questex’s Fierce Biotech Announces 2025 Fierce CRO Award Winners
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Questex’s Fierce Biotech today announces the winners of the second annual Fierce CRO Awards.Fierce Pharma Asia—Pfizer CEO talks bispecific deal; Otsuka's kidney disease win
Pfizer's CEO discussed the extensive due diligence the company has conducted on the 3SBio PD-1xVEGF deal. | Pfizer's CEO discussed the extensive due diligence the company has conducted on the 3SBio PD-1xVEGF deal. Otsuka detailed its phase 3 data in the kidney disease IgAN. Novartis is pressing for a speedy ruling in its Entresto patent litigation against MSN Pharmaceuticals.
Read more news
Top Media & Internet Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding FierceBiotech
Sign Up For FreeTo access detailed company insights
Fierce Biotech is a leading source of news and reports focused on the biotechnology sector, covering topics such as clinical data, cell and gene therapy, and venture capital. The company provides insights into the latest developments in medtech, diagnostics, and biologics, catering to professionals in the life sciences industry. It also hosts event... Read More
